Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0N4PC
|
||||
| Former ID |
DIB011215
|
||||
| Drug Name |
RU-46556
|
||||
| Indication | Endometrial cancer [ICD9: 182; ICD10:C54.1] | Terminated | [1] | ||
| Company |
Aventis Pharma AG
|
||||
| Structure |
|
Download2D MOL |
|||
| Canonical SMILES |
C12=C3C(=CC(=O)CC3)CC[C@H]1[C@H]1[C@](C[C@@H]2c2ccc(SC)<br />cc2)([C@@]2(OCC=C2)CC1)C
|
||||
| CAS Number |
CAS 116680-11-6
|
||||
| Target and Pathway | |||||
| Target(s) | Progesterone receptor | Target Info | Modulator | [2] | |
| KEGG Pathway | Oocyte meiosis | ||||
| Progesterone-mediated oocyte maturation | |||||
| Pathway Interaction Database | Cellular roles of Anthrax toxin | ||||
| Reactome | Nuclear signaling by ERBB4 | ||||
| Nuclear Receptor transcription pathway | |||||
| WikiPathways | Ovarian Infertility Genes | ||||
| Signaling by ERBB4 | |||||
| Nuclear Receptors | |||||
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003252) | ||||
| REF 2 | New analogues of mifepristone with more dissociated antiprogesterone activities. J Steroid Biochem. 1989;34(1-6):413-7. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.